home / stock / lgvn / lgvn news


LGVN News and Press, Longeveron Inc. From 11/23/21

Stock Information

Company Name: Longeveron Inc.
Stock Symbol: LGVN
Market: NASDAQ
Website: longeveron.com

Menu

LGVN LGVN Quote LGVN Short LGVN News LGVN Articles LGVN Message Board
Get LGVN Alerts

News, Short Squeeze, Breakout and More Instantly...

LGVN - Pasithea Therapeutics, Petros Pharmaceuticals leads healthcare gainers; Longeveron, PainReform among major losers

Gainers: Pasithea Therapeutics (NASDAQ:KTTA) +257%, Petros Pharmaceuticals (NASDAQ:PTPI) +73%, Gracell Biotechnologies (NASDAQ:GRCL) +64%, iSpecimen (NASDAQ:ISPC) +43%, Qualigen Therapeutics (NASDAQ:QLGN) +33%. Losers: Longeveron (NASDAQ:LGVN) -36%...

LGVN - Longeveron pares back gains after social media-driven rally

Following a sharp rally on Monday thanks to its popularity on social media, Longeveron (LGVN -32.7%) has lost more than a quarter of value in morning hours on above-average volume. Over ~8.8M Longeveron (NASDAQ:LGVN) shares have changed hands compared to the 65-day average volume of ~8.0M sha...

LGVN - Longeveron momentum continues for a third day as shares up 151%

Shares of Longeveron (LGVN +165.9%), which began a dramatic rise on Nov. 18 following Rare Pediatric Disease ("RPD") designation for Lomecel-B, are continuing to skyrocket. On Nov. 18, shares closed up 135%. The following day, the closed up another 46%. The RPD designation is for Hy...

LGVN - 4 Biotech Stocks To Watch This Week

Check Out These 4 Trending Biotech Stocks Right Now Biotech stocks have been among the most exciting stocks to invest in the stock market . The reason being, this is a high-risk, high-reward industry that could appeal to a certain group of investors. The stock movement within th...

LGVN - Longeveron up 100% after FDA approves its Lomecel-B medical product

Longeveron Inc ( NASDAQ: LGVN ) is a clinical biotech firm that develops cellular therapies to treat life-threatening and aging-related conditions. It announced that it had received approval from the FDA for the RPD (Rare Pediatric Disease) designation for its Lomecel-B to treat...

LGVN - SAVA, GTEC and RAAS among mid-day movers

Gainers: Greenland Technologies Corporation (NASDAQ:GTEC) +71%. Longeveron (NASDAQ:LGVN) +37%. Aurora (NASDAQ:AUR) +31%. Bakkt (NYSE:BKKT) +26%. FedNat Holding Company (NASDAQ:FNHC) +18%. UWM Holdings Corporation (NYSE:UWMC) +18%. SCYNEXIS (NASDAQ:SCYX) +16%. Kornit (NASDAQ:KRNT) +15%. Aspira...

LGVN - Longeveron, SCYNEXIS leads healthcare gainers; Connect Biopharma, Flora Growth among major losers

Gainers: Longeveron (NASDAQ:LGVN) +36%, SCYNEXIS (NASDAQ:SCYX) +16%, Context Therapeutics (NASDAQ:CNTX) +15%, Akoya Biosciences (NASDAQ:AKYA) +15%, Aspira Women's Health (NASDAQ:AWH) +15%. Losers: Connect Biopharma (NASDAQ:CNTB) -54%, Flora Gr...

LGVN - Longeveron hot streak continues as biotech up another 75% premarket

On the heels of a 135% gain yesterday, shares of Longeveron (NASDAQ:LGVN) are up another 75% in premarket trading. Shares skyrocketed yesterday after the company recveived FDA Rare Pediatric Disease Designation for Lomecel-B, its candidate for Hypoplastic Left He...

LGVN - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re starting off the final day of trading this week with a look at the biggest pre-market stock movers for Friday! Source: Shutterstock There’s plenty of news moving stock today...

LGVN - Do These Top Penny Stocks Have Upside Potential in November?

3 Penny Stocks to Add to Your November 2021 Watchlist While November is more than halfway done, penny stocks continue to see bullish momentum. Although it has been a shaky month and past few months for both penny stocks and blue chips , it’s clear that investors are hoping fo...

Previous 10 Next 10